BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37676252)

  • 1. Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
    Dookwah M; Wagner SK; Ishihara M; Yu SH; Ulrichs H; Kulik MJ; Zeltner N; Dalton S; Strauss KA; Aoki K; Steet R; Tiemeyer M
    Hum Mol Genet; 2023 Dec; 32(24):3323-3341. PubMed ID: 37676252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological insights on two siblings with GM3 synthase deficiency due to novel compound heterozygous ST3GAL5 variants.
    Watanabe S; Lei M; Nakagawa E; Takeshita E; Inamori KI; Shishido F; Sasaki M; Mitsuhashi S; Matsumoto N; Kimura Y; Iwasaki M; Takahashi Y; Mizusawa H; Migita O; Ohno I; Inokuchi JI
    Brain Dev; 2023 May; 45(5):270-277. PubMed ID: 36690566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygous variants within two conserved sialyltransferase motifs of
    Rudy N; Aoki K; Ananth A; Holloway L; Skinner C; Hurst A; Tiemeyer M; Steet R
    JIMD Rep; 2023 Mar; 64(2):138-145. PubMed ID: 36873089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.
    Boccuto L; Aoki K; Flanagan-Steet H; Chen CF; Fan X; Bartel F; Petukh M; Pittman A; Saul R; Chaubey A; Alexov E; Tiemeyer M; Steet R; Schwartz CE
    Hum Mol Genet; 2014 Jan; 23(2):418-33. PubMed ID: 24026681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total loss of GM3 synthase activity by a normally processed enzyme in a novel variant and in all ST3GAL5 variants reported to cause a distinct congenital disorder of glycosylation.
    Indellicato R; Parini R; Domenighini R; Malagolini N; Iascone M; Gasperini S; Masera N; dall'Olio F; Trinchera M
    Glycobiology; 2019 Mar; 29(3):229-241. PubMed ID: 30576498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency.
    Aoki K; Heaps AD; Strauss KA; Tiemeyer M
    Clin Mass Spectrom; 2019 Nov; 14 Pt B():106-114. PubMed ID: 34917767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total metabolic flow of glycosphingolipid biosynthesis is regulated by UDP-GlcNAc:lactosylceramide beta 1-->3N-acetylglucosaminyltransferase and CMP-NeuAc:lactosylceramide alpha 2-->3 sialyltransferase in human hematopoietic cell line HL-60 during differentiation.
    Nakamura M; Tsunoda A; Sakoe K; Gu J; Nishikawa A; Taniguchi N; Saito M
    J Biol Chem; 1992 Nov; 267(33):23507-14. PubMed ID: 1429695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase).
    Zebda N; Pedron S; Rebbaa A; Portoukalian J; Berthier-Vergnes O
    FEBS Lett; 1995 Apr; 362(2):161-4. PubMed ID: 7720864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).
    Shishido F; Uemura S; Nitta T; Inokuchi JI
    Glycoconj J; 2017 Oct; 34(5):651-659. PubMed ID: 28808804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression machinery of GM4: the excess amounts of GM3/GM4S synthase (ST3GAL5) are necessary for GM4 synthesis in mammalian cells.
    Uemura S; Go S; Shishido F; Inokuchi J
    Glycoconj J; 2014 Feb; 31(2):101-8. PubMed ID: 23999868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside.
    Chigorno V; Tettamanti G; Sonnino S
    J Biol Chem; 1996 Sep; 271(36):21738-44. PubMed ID: 8702969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles for UDP-GlcNAc 2-epimerase/ManNAc 6-kinase outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM3 and GD3 biosynthesis, proliferation, and apoptosis, and ERK1/2 phosphorylation.
    Wang Z; Sun Z; Li AV; Yarema KJ
    J Biol Chem; 2006 Sep; 281(37):27016-28. PubMed ID: 16847058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of GM3 synthase deficiency by spatially controlled, rAAV-mediated ST3GAL5 delivery.
    Yang H; Brown RH; Wang D; Strauss KA; Gao G
    JCI Insight; 2023 May; 8(9):. PubMed ID: 37014712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts.
    Liu Y; Su Y; Wiznitzer M; Epifano O; Ladisch S
    Glycobiology; 2008 Aug; 18(8):593-601. PubMed ID: 18480157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
    Müthing J; Cacić M
    Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM3 synthase deficiency in non-Amish patients.
    Heide S; Jacquemont ML; Cheillan D; Renouil M; Tallot M; Schwartz CE; Miquel J; Bintner M; Rodriguez D; Darcel F; Buratti J; Haye D; Passemard S; Gras D; Perrin L; Capri Y; Gérard B; Piton A; Keren B; Thauvin-Robinet C; Duffourd Y; Faivre L; Poe C; Pervillé A; Héron D; Thévenon J; Arnaud L; LeGuern E; La Selva L; Vetro A; Guerrini R; Nava C; Mignot C
    Genet Med; 2022 Feb; 24(2):492-498. PubMed ID: 34906476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosphingolipid glycosyltransferases in human fetal brain.
    Percy AK; Gottfries J; Vilbergsson G; Månsson JE; Svennerholm L
    J Neurochem; 1991 May; 56(5):1461-5. PubMed ID: 1901591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients.
    Inamori KI; Inokuchi JI
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanoma.
    Shimizu T; Nagane M; Suzuki M; Yamauchi A; Kato K; Kawashima N; Nemoto Y; Maruo T; Kawakami Y; Yamashita T
    Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129723. PubMed ID: 32861756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.